Welcome : Guest

Sinovac Biotech, Ltd. (China) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Sinovac Biotech, Ltd., which is principally involved in Biopharmaceuticals Business. Illustrated with 36 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-65383
Price: $1800
Company Type: Public
Pages: 39
Date: November 2016
Market Data Tables: 36

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Sinovac Biotech Ltd.'s Sales by Product Segment Worldwide (2015) in Percentage for Hepatitis A Vaccines, Hepatitis A&B Vaccines, Influenza Vacciness, Mumps Vacciness, and H5N1 Vaccines......3
Table 2: Sinovac Biotech Ltd.'s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Mainland China and Other......4
Antivirals......6
Table 3: Antiviral Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antiviral Drugs, Monoclonal Antibodies, Vaccines and Others......6
Vaccines......7
Table 4: Vaccines Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Adult Prophylactic Vaccines (USD 8.5bn), Pediatric Vaccines (USD 16.7bn) and Others......7
Table 5: Human Vaccine Market by Category in China (2015) - Percentage Share Breakdown by Volume for Expanded Program on Immunization (EPI), and Extra Expanded Program on Immunization (EPI)......8
Hepatitis B......9
Table 6: No. of Hepatitis B Patients by Region in Europe (2015) - Percentage Market Share Breakdown by Volume for Eastern Europe, and Western Europe......9
Table 7: No. of Hepatitis B Patients by Country in Eastern Europe (2015) - Percentage Market Share Breakdown by Volume for Hungary, Poland, and Romania......10
Table 8: No. of Hepatitis B Patients by Country in West Europe (2015) - Percentage Market Share Breakdown by Volume for France, Germany, Italy, Netherlands, Spain, United Kingdom, and Others......11
Hepatitis C......12
Table 9: Hepatitis Drug Market in China (2015) in Rmb Million......12
Table 10: Hepatitis C Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno Modulator, Polymerase Inhibitor, Protease Inhibitors, and Others* (Includes Ribavirin)......13
Table 11: Hepatitis C Market by Genotype Worldwide (2015) - Percentage Share Breakdown by Value for Genotype 1, Genotype 2 and Others......14
Table 12: Hepatitis C Virus Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno-Modulator, Polymerase Inhibitor, Protease Inhibitors, Ribavirin, and Others......15
Table 13: Hepatitis C Virus Market by Patient Conditions in Europe (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......16
Table 14: No. of Hepatitis C Virus (HCV) Patients by Category in European Union (EU) (2015) - Percentage Market Share Breakdown for GT1, and Non-GT1......17
Table 15: Hepatitis C Virus Market by Patient Conditions in the US (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......18
Table 16: Health Insurance for Hepatitis C Virus (HCV) by Type in the US (2015) - Percentage Market Share Breakdown by Value for Commercial, Dual (Medicare and Medicaid), Medicaid, Medicare (Non- Dual), Prison, Uninsured, and Veteran Affairs......19
Table 17: No. of Hepatitis C Virus (HCV) Patients by Category in the US (2015) - Percentage Market Share Breakdown for GT1 HCV, GT2/3 HCV, and Others......20
Haemophilia B......21
Table 18: Market Shares of Leading Haemophilia B Treatment Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value Sales for Pfizer, Inc. (Benefix) and Others......21
Table 19: Market Shares of Leading Haemophilus B Conjugate Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hiberix), and Others......22
Hepatitis B Drugs......23
Table 20: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......23
Table 21: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......24
Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs......25
Table 22: Market Shares of Leading Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Co (BMY), GlaxoSmithKline Plc (GSK), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Vertex Pharmaceuticals, Inc. (VRTX), and Others......25
Vaccines......26
Table 23: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......26
Diphtheria and Tetanus Vaccines......27
Table 24: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......27
Hepatitis A Vaccines......28
Table 25: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......28
Hepatitis B (Recombinant) Vaccines......29
Table 26: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......29
Hepatitis A and Typhoid Polysaccharide Vaccines......30
Table 27: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......30
Human Papillomavirus Vaccines......31
Table 28: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......31
Human Rotavirus Vaccines......32
Table 29: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......32
Influenza Vaccines......33
Table 30: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......33
Measles, Mumps and Rubella Vaccines......34
Table 31: Market Shares of Leading Measles, Mumps and Rubella Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Priorix), and Others......34
Tetanus Toxoid, reduced Diphthera Vaccines......35
Table 32: Market Shares of Leading Tetanus Toxoid, reduced Diphthera Vaccine Manufacturers in India (2014) - Percentage Breakdown by Value Sales for GlaxoSmithKline Plc (Boostrix), and Others......35
Typhoid Vaccines......36
Table 33: Market Shares of Leading Typhoid Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Typherix), and Others......36
Varilrix Vaccines......37
Table 34: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......37
Table 35: Sinovac Biotech Ltd.'s Sales by Geographic Region Worldwide (2013-2014) in Percentage for Mainland China and Others......38
Table 36: Sinovac Biotech Ltd.'s Sales by Product Segment Worldwide (2013-2014) in Percentage for Inactivated Hepatitis Vaccines (Hepatitis A Vaccine and Hepatitis A&B Vaccine), Influenza Vaccines and Others......39